Patient Guide: PREEMIE: Study for Treatment of PDA in Premature Infants

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06587282
Status: 🟢 Enrolling Now
Condition: Patent Ductus Arteriosus (PDA)
Phase: NA

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Sacramento, California
  • • San Diego, California
  • • Hollywood, Florida
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

PREEMIE: Study for Treatment of PDA in Premature Infants - Join Clinical Trial NCTNCT06587282

How to Join This Clinical Trial - NCTNCT06587282

Learn how to participate in this NA trial studying an investigational therapy for Patent Ductus Arteriosus (PDA). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Patent Ductus Arteriosus (PDA). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Patent Ductus Arteriosus (PDA)
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06587282 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Sacramento, California 95817 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 92123 - United States

Status: RECRUITING

Clinical Research Site

Hollywood, Florida 33021 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33155 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30342 - United States

Status: RECRUITING

Clinical Research Site

Saint Louis, Missouri 63110 - United States

Status: RECRUITING

Clinical Research Site

Columbus, Ohio 43215 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Memphis, Tennessee 38103 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75390 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Milwaukee, Wisconsin 53226 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Patent Ductus Arteriosus (PDA):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships